Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur. J. Cancer, vol.49, pp.1374-1403, 2013. ,
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup, Ann. Oncol, vol.21, issue.5, pp.23-30, 2010. ,
Ovarian cancer pathogenesis: a model in evolution, J. Oncol, p.932371, 2009. ,
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup, Ann. Oncol, vol.24, issue.6, pp.24-32, 2013. ,
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.23, issue.7, pp.20-26, 2012. ,
Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors, Int J. Gynecol. Cancer J. Int. Gynecol. Cancer Soc, vol.18, pp.446-452, 2008. ,
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas, J. Clin. Oncol, vol.25, pp.2281-2287, 2007. ,
Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer, Br. J. Cancer, vol.107, pp.1327-1336, 2012. ,
WNT7A/?-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer, Oncogene, vol.34, pp.3452-3462, 2015. ,
Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease, J. Biochem, vol.149, pp.121-130, 2011. ,
The fibroblast growth factor signaling pathway, Wiley Interdiscip. Rev. Dev. Biol, vol.4, pp.215-266, 2015. ,
Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence, Science, vol.249, pp.1567-1570, 1990. ,
Dual mode of signal transduction by externally added acidic fibroblast growth factor, Cell, vol.76, pp.1039-1051, 1994. ,
Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization, Mol. Cell Biol, vol.16, pp.270-280, 1996. ,
The neurotrophic activity of fibroblast growth factor 1 (FGF1) depends on endogenous FGF1 expression and is independent of the mitogen-activated protein kinase cascade pathway, J. Biol. Chem, vol.271, pp.2801-2811, 1996. ,
FGF1 inhibits p53-dependent apoptosis and cell cycle arrest via an intracrine pathway, Oncogene, vol.24, pp.7839-7849, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00101326
Fibroblast growth factor 1 inhibits p53-dependent apoptosis in PC12 cells, Apoptosis Int. J. Program Cell Death, vol.12, pp.1377-1387, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00172706
FGF1 nuclear translocation is required for both its neurotrophic activity and its p53-dependent apoptosis protection, Biochim. Biophys. Acta BBA-Mol. Cell Res, vol.1793, pp.1719-1727, 2009. ,
FGF1 C-terminal domain and phosphorylation regulate intracrine FGF1 signaling for its neurotrophic and anti-apoptotic activities, Cell Death Dis, vol.7, p.2079, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01872524
A novel single-chain variable fragment antibody against FGF-1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF-1, IUBMB Life, vol.63, pp.129-137, 2011. ,
Identification of new FGF1 binding partners-implications for its intracellular function, IUBMB Life, vol.68, pp.242-251, 2016. ,
Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells, Proc. Natl Acad. Sci. USA, vol.89, pp.10691-10695, 1992. ,
,
protein induces the expression and extracellular appearance of acidic fibroblast growth factor, J. Biol. Chem, vol.270, pp.17457-17467, 1995. ,
Serum-starvation induces the extracellular appearance of FGF-1, Biochim Biophys. Acta, vol.1312, pp.27-38, 1996. ,
Binding of FGF-1 variants to protein kinase CK2 correlates with mitogenicity, EMBO J, vol.21, pp.4058-4069, 2002. ,
Cloning of an intracellular protein that binds selectively to mitogenic acidic fibroblast growth factor, Biochem. J, vol.336, pp.213-222, 1998. ,
Identification of ribosome-binding protein p34 as an intracellular protein that binds acidic fibroblast growth factor, J. Biol. Chem, vol.277, pp.23864-23871, 2002. ,
Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1), PLoS ONE, vol.9, p.90687, 2014. ,
Surfing the p53 network, Nature, vol.408, pp.307-310, 2000. ,
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, pp.293-299, 1995. ,
Drugging the p53 pathway: understanding the route to clinical efficacy, Nat. Rev. Drug Discov, vol.13, pp.217-236, 2014. ,
p53 Has a direct apoptogenic role at the mitochondria, Mol. Cell, vol.11, pp.577-590, 2003. ,
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis, Science, vol.303, pp.1010-1014, 2004. ,
Mitochondrial p53 activates bak and causes disruption of a Bak-Mcl1 complex, Nat. Cell Biol, vol.6, pp.443-450, 2004. ,
The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.483, pp.603-607, 2012. ,
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells, Br. J. Cancer, vol.70, pp.914-921, 1994. ,
Protein-phospholipid interactions in nonclassical protein secretion: problem and methods of study, Int. J. Mol. Sci, vol.14, pp.3734-3772, 2013. ,
Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters, Nucleic Acids Res, vol.42, pp.7666-7680, 2014. ,
Prospective therapeutic applications of p53 inhibitors, Biochem. Biophys. Res. Commun, vol.331, pp.726-736, 2005. ,
Resistance to fasmediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP, Oncogene, vol.17, pp.931-939, 1998. ,
The mitochondrial p53 pathway, Biochim. Biophys. Acta, vol.1787, p.414, 2009. ,
A small molecule inhibitor of inducible heat shock protein 70, Mol. Cell, vol.36, pp.15-27, 2009. ,
Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors, Pharm. Res, vol.23, pp.1324-1331, 2006. ,
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies, Oncotarget, vol.7, pp.44735-44762, 2016. ,
In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation, J. Assist. Reprod. Genet, vol.32, pp.1551-1559, 2015. ,
Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells, Gynecol. Oncol, vol.108, pp.632-640, 2008. ,
Genetics and genomics of ovarian sex cordstromal tumors: genetics and genomics of ovarian sex cord-stromal tumors, Clin. Genet, vol.91, pp.285-291, 2017. ,
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells, Nat. Cell Biol, vol.3, pp.245-252, 2001. ,
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response, Mutat Res. Mutat. Res, vol.704, pp.12-20, 2010. ,
Protein and its function based on a subcellular localization, J. Cell Biochem, vol.112, pp.3502-3506, 2011. ,
Caspase 3 inactivation to suppress fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21, Oncogene, vol.18, pp.1239-1244, 1999. ,
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer, J. Clin. Invest, vol.120, pp.3594-3605, 2010. ,
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer, BMC Cancer, vol.11, p.399, 2011. ,
HSP27 Knockdown Increases cytoplasmic p21 and cisplatin sensitivity in ovarian carcinoma cells, Oncil. Res. Featur. Preclin. Clin. Cancer Ther, vol.23, pp.119-128, 2016. ,
Cleavage of CDK Inhibitor p21Cip1/Waf1 by caspases is an early Event during DNA damage-induced apoptosis, J. Biol. Chem, vol.273, pp.19207-19212, 1998. ,
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents, Cancer Cell, vol.5, pp.163-175, 2004. ,
The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function, J. Biol. Chem, vol.287, pp.20866-20875, 2012. ,
MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling, Mol. Cancer Res. Mcr, vol.4, pp.873-883, 2006. ,
TRAF6 restricts p53 mitochondrial translocation, apoptosis, and tumor suppression, Mol. Cell, vol.64, pp.803-814, 2016. ,
Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity, Proc. Natl Acad. Sci. USA, vol.110, pp.17356-17361, 2013. ,
Forkhead box O3A (FOXO3) and the mitochondrial disulfide relay carrier (CHCHD4) regulate p53 protein nuclear activity in response to exercise, J. Biol. Chem, vol.291, pp.24819-24827, 2016. ,
Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer, Oncogene, vol.29, pp.1155-1166, 2010. ,
Mitochondrial localization of the low level p53 protein in proliferative cells, Biochem. Biophys. Res. Commun, vol.387, pp.772-777, 2009. ,
Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F 1 F 0 -ATP synthase, Cell Cycle, vol.12, pp.2781-2793, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01871462
Fibroblast growth factor-1 interacts with the glucoseregulated protein GRP75/mortalin, Biochem. J, vol.343, issue.2, pp.461-466, 1999. ,
Three faces of mortalin: a housekeeper, guardian and killer, Exp. Gerontol, vol.42, pp.263-274, 2007. ,
Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin, Int. J. Cancer, vol.129, pp.1806-1814, 2011. ,
Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy, Cell Death Differ, vol.18, pp.1046-1056, 2011. ,
An improved method for staining cell colonies in clonogenic assays, Cytotechnology, vol.54, pp.85-88, 2007. ,